Gilead Sciences

GILD73

High Growth

$89.10arrow_drop_up0.53%$0.47

High Growth

S&P500

GILD73

$89.10

arrow_drop_up0.53%$0.47

High Growth

S&P500

Performance History

Key Stats
Open	$88.11
Prev. Close	$87.75
EPS	0.09

Next Earnings Date	Apr 3, 2025

	LOW	HIGH
Day Range	87.63	89.05
52 Week Range	62.07	98.83

Ratios







EPS	0.09

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Gilead Sciences (GILD)

Gilead Sciences Inc. (GILD) is a leading biopharmaceutical company focused on discovering, developing, and commercializing innovative drugs for the treatment of various diseases. The company's mission is to advance the care of patients suffering from life-threatening illnesses. Gilead Sciences has a diverse portfolio of products that span areas such as HIV/AIDS, liver diseases, oncology, respiratory diseases, and inflammation. The company is committed to improving patients' lives through its research and development efforts.

Gilead Sciences Inc. has a strong stock price history, with consistent growth over the years. The stock has shown resilience even during challenging market conditions. As of the latest quote, GILD is trading at $65.12 per share. The stock has experienced both highs and lows within the 52-week range of $57.81 to $85.97. The day range for GILD is $64.20 to $66.05, reflecting the current market volatility. Gilead Sciences has a market cap of $81.63 billion, indicating its significant presence in the industry.

Websitecall_made

Sector: Healthcare
Industry: Drug Manufacturers—General
CEO: Mr. Daniel P. O'Day
Headquarters: Foster City
Employees: 17000
Exchange: NASDAQ

Keep an eye on Gilead Sciences

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Gilead Sciences 's (GILD) price per share?

The current price per share for Gilead Sciences (GILD) is $89.11. The stock has seen a price change of $0.48 recently, indicating a 0.54% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Gilead Sciences (GILD)?

For Gilead Sciences (GILD), the 52-week high is $98.83, which is 10.92% from the current price. The 52-week low is $62.07, the current price is 43.56% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Gilead Sciences (GILD) a growth stock?

Gilead Sciences (GILD) has shown an average price growth of -7.34% over the past three years. It has received a score of 63 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Gilead Sciences as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Gilead Sciences (GILD) stock price performance year to date (YTD)?

As of the latest data, Gilead Sciences (GILD) has a year-to-date price change of 7.05%. Over the past month, the stock has experienced a price change of 3.26%. Over the last three months, the change has been 19.2%. Over the past six months, the figure is 31.23%. Looking at a longer horizon, the five-year price change stands at 37.34%.

help

Is Gilead Sciences (GILD) a profitable company?

Gilead Sciences (GILD) has a net income of $5.61B, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 41.96% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $27.12B, although specific revenue growth data is currently not available. The gross profit is $27.12B. Operating income is noted at $7.6B. Furthermore, the EBITDA is $10.48B.

help

What is the market capitalization of Gilead Sciences (GILD)?

Gilead Sciences (GILD) has a market capitalization of $110.46B. The average daily trading volume is 88.51, indicating the stock's liquidity and investor engagement.